Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr.…
Dow eked out a slight gain. Yes. It's only 30 stocks. But 20 were higher. And shows that there's more to the market than tech. Solid pops for $PG (nice earnings) as well as $HD $JNJ $CRM (what SaaS-pocalypse?) $KO $WMT $MCD $SHW.
? This Week in Visuals ? $ASML ASML ? $JNJ J&J ? $UNH UnitedHealth ?? $BAC Bank of America ? $MS Morgan Stanley ? $BLK BlackRock ? $SCHW Schwab ? $DPZ Domino's https://t.co/jAMf1PVW2I
? This Week in Visuals ? $ASM ASML ? $JNJ J&J ? $UNH UnitedHealth ?? $BAC Bank of America ? $MS Morgan Stanley ? $BLK BlackRock ? $SCHW Schwab ? $DPZ Domino's https://t.co/jAMf1PVW2I
? This Week in Visuals ? $ASM ASML ? $JNJ J&J ? $UNH UnitedHealth ?? $BAC Bank of America ? $MS Morgan Stanley ? $BLK BlackRock ? $SCHW Schwab ? $DPZ Domino's https://t.co/jAMf1PVW2I
Healthcare strengthened throughout the day, with the $XLV ending higher by 2.5%, its best session in about two months. $JNJ has been a strong performer, but its recent pullback has it near a prior S/R area, as well as the 200-day sma. https://t.co/gN8EWu2RHK
$JNJ ? I gave you plan in tweet in morning, this was homerun on shorts/puts for traders No-where you will find such education ,Live premarket planning, Live guidance with Life Changing System I explained bearish bias in morning, and it paid for lunch and breakfast for traders!…
23 analysts rate JNJ Buy on consensus.
Consensus price target: $279.41 (+4.41% upside from $267.61)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Schmid Timothy EVP, WW Chair, MedTech | Sep 2, 2026 | Sale | 22,527 | $6.19M |
| Taubert Jennifer L EVP, WWC. Innovative Medicine | Aug 17, 2026 | Sale | 15,000 | $3.95M |
| Duato Joaquin director, CEO and Chairman of the Board | Aug 13, 2026 | Sale | 20,976 | $5.5M |
| Duato Joaquin director, CEO and Chairman of the Board | Aug 13, 2026 | Sale | 102,315 | $26.7M |
| Forminard Elizabeth EVP, Chief Legal Officer | Aug 6, 2026 | Sale | 9,344 | $2.41M |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $94.19B | 0% | $26.8B |
| 2025 | $94.19B | +6.05% | $26.8B |
| 2024 | $88.82B | 0% | $14.07B |
Stock data for JNJ: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics